Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
How should clinicians prescribe opioids for cancer-related pain in patients who use cocaine or methamphetamines?
Clinicians treating cancer-related pain must consider whether and how to prescribe opioids to patients who…
Could a cancer drug hold the key to a HIV cure?
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying…
Do ‘forever chemicals’ increase breast cancer risk?
A University of Massachusetts Amherst (USA) cancer epidemiology researcher will explore for the first time…
Advanced bowel cancers have very few ‘molecular flags’, hindering immune recognition
Advanced bowel cancer cells have very few ‘molecular flags’ on their surface, helping to explain why they may be hard…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.